In CRS with and without nasal polyps, medical treatment, including nasal and oral corticosteroids, is the first therapeutic option. The treatment of CRS still remains an unmet need ...
Study participants were symptomatic even with standard of care treatment (intranasal corticosteroids). A 12 to -24 week post-treatment follow ... The co-primary endpoints were change from baseline in ...
Standard care for CRSwNP consists of corticosteroids in the nose ... and 25% to 30% of them develop nasal polyps as a result. Sanofi and Regeneron have said that CRSwNP has been helping to ...
WAYPOINT co-primary investigator Brian Lipworth, Ninewells Hospital University of Dundee, explained: “Patients diagnosed with nasal polyps continue to experience significant burden including repeat ...
Exposure to irritants has been shown to increase nasal symptoms and cause exacerbations ... scale (VAS): VAS less than 3 (mild: intranasal corticosteroids); VAS above 3–10 (moderate to severe ...
CRSwNP is an inflammatory condition which results in the growth of nasal polyps in the nose that ... often leading to prolonged exposure to corticosteroids, which can be harmful.